Sanofi (NYSE: SNY) and MannKind Corporation (Nasdaq: MNKD) announced today that Afrezza® (insulin human) Inhalation Powder, the only inhaled insulin ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE